Patient reported outcomes during the first month following anterior and posterior total hip arthroplasty and hip resurfacing Authors: Laura Elisa Streck, Bernhard Springer, Lyubomir Haralambiev, Kimi Spilo, Ulrich Bechler, Friedrich Boettner Published: 2025 ABSTRACT BackgroundSurgical treatment for osteoarthritis of the hip includes hip resurfacing (HR) and total hip arthroplasty (THA) via various surgical approaches. The discussion about the benefits and preferability of each procedure is highly controversial. We aimed to quantify the patients’ utilization of opioids within the first 30 days following surgery and hypothesized that there are no differences in pain, medication, ability to walk, and function between direct anterior approach THA (DAA-THA), posterior approach THA (PA-THA), and HR.MethodsThis retrospective study evaluated 207 hips in 199 patients (DAA: 126 hips, PA: 59, HR: 21), who underwent surgery for primary osteoarthritis between 2020 and 2022. Patients used an app (SeamlessMD, Toronto, Canada) to report pain, utilization of opioids, additional pain medication, walking distance, swelling, and wound drainage for 30 days and HOOS-JR and satisfaction at one month after surgery. Results were compared between the groups after adjusting for age and BMI and patient satisfaction was correlated with pain and function.ResultsOpioid cessation was 99% 20 days after surgery. HOOS-JR improvement from pre- to postoperative was 23 points on average (-29-82, SD 15) and was significant in all groups (p < 0.001). No differences in pain, the dosage of opioids and complications were found between DAA-THA, PA-THA and HR.ConclusionThe current data showed a high rate of opioid cessation (99%) within 3 weeks following hip reconstructive surgery. DAA-THA, PA-THA, and HR provided comparable opioid usage, function, and a low early complication rate within the first month after surgery.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12891-025-09337-w. Introduction Approximately 27 million Americans are affected by osteoarthritis and the lifetime risk of developing symptomatic osteoarthritis of the hip has been estimated at 25% [1, 2]. When conservative treatment for this condition fails, surgical options include hip resurfacing (HR) or total hip arthroplasty (THA). The latter can be performed using various surgical approaches such as a direct anterior or a posterior approach (DAA, PA). To date, the discussion about which procedures and approaches are preferable is highly controversial. HR preserves bone stock and may prevent dislocation by maintaining the natural head size. Some studies showed higher activity levels following HR compared to THA [3, 4]. The duration of surgery was found to be longer for HR while the hospital stay was shorter [5]. However, patient satisfaction and functional outcome scores did not differ following HR or THA [6, 7]. Proponents of a DAA for THA quote a shorter hospital stay, earlier reduction of pain and earlier ability of walking without walking aids when using this approach [8–10]. In contrasts, other studies found no differences for pain, function and walking ability [11–13]. Hence, while this field of research has come into focus in past years, both literature and expert opinions as well as patient information material are still inconsistent. Daily clinical practice shows that patients who are candidates for reconstructive hip surgery are often unsure about what is the most suitable procedure for them. The current study focuses on outcomes during the early postoperative period. It assesses opioid usage and patient related outcome measures during the first month following DAA-THA PA-THA and HR. This is especially relevant as gaining more information on postoperative courses from the patient’s point of view will help to improve managing patients’ expectations as for surgeons it can be difficult to communicate appropriate expectations including postoperative pain or an adequate level of activity. An example for the problem can be found in a study by Alsaleem et al. (2021) reporting that over 60% of patients have a fear of movement following THA [14]. Knowledge about a surgical procedure influences patients’ expectations and emotions, those again have reciprocal influence on the patients’ behavior and attitude [15]. Furthermore, opioid usage following orthopedic procedures is common but also controversial. It has been suggested that too many opioids may be prescribed, partly as doctors may fear patient dissatisfaction if done otherwise. While patient satisfaction does not seem to depend on opioid prescription, the prolonged use of opioids has been shown to be associated with an increased risk for postoperative complications in a review by Bolarinwa et al. [14, 15]. Several studies reported on in-hospital or overall opioid dosages following hip arthroplasty [14, 16, 17]. The current study aims to provide additional information by reporting closer time intervals, differentiating between surgical approaches and correlating opioid use with PROMs. It aims to quantify the patients’ pain and utilization of narcotics within the first 30 days following DAA-THA, PA-THA and HR. It was hypothesized that there are no differences between DAA-THA, PA-THA and HR regarding pain levels, utilization of pain medications, wound drainage, swelling, walking ability and complications over a course of 30 days after surgery and that within 30 days, the vast majority of patients (>95%) will be satisfied with the outcome of the surgery, have stopped taking opiods and show better function than preoperatively, independent of the type of procedure. Methods This is a retrospective study of patients who underwent primary hip resurfacing (HR) or total hip arthroplasty (THA) between 2020 and 2022 by the senior author at the senior author’s institution. Cases were included if (1) indication for surgery was primary osteoarthritis or aseptic osteonecrosis of the hip, (2) patients used an app (SeamlessMD, Toronto, Canada) to report their health status during the first month after surgery, which was a regular part of the standard postoperative care (see “data collection” and Table 1 for details). One hip in one patient was excluded due to posttraumatic osteoarthritis as indication for surgery. 207 hips in 199 patients met the criteria and were included in the study. Patients were grouped by procedure and surgical approach. The cohort comprised 126 hips (123 patients) with DAA-THA, 59 hips (56 patients) with PA-THA, and 21 hips (19 patients) with HR. The study received approval from the author’s institutional review board. Table 1Outcomes and their measurement as assessed in the current study. For further information see main text “Methods”Assessment toolMeasurementTime of assessmentFunctionHip disability and Osteoarthritis Outcome Score – Joint Reconstruction (HOOS-JR)0–100 (worst to best)Preoperative +1 month postoperativePainNumeric Rating Scale (NRS)0–10 (no pain to worst pain)During 30 days postoperativeOpioidsMorphin Equivalent Dose (MED)mgDuring 30 days postoperativeCelecoxib, Meloxicam,AcetaminophenDosemgDuring 30 days postoperativeDrainageDo you have wound drainage?Yes/no/bandage still onDuring 30 days postoperativeSwellingDo you have significant swelling?Yes/noDuring 30 days postoperativeForgotten JointHave you forgotten about your joint replacement?0–100%At 1 month postoperativeSastisfactionKnowing what you know now, how likely would you be to have your joint replaced in the future?0–100%At 1 month postoperative Table 1Outcomes and their measurement as assessed in the current study. For further information see main text “Methods”Assessment toolMeasurementTime of assessmentFunctionHip disability and Osteoarthritis Outcome Score – Joint Reconstruction (HOOS-JR)0–100 (worst to best)Preoperative +1 month postoperativePainNumeric Rating Scale (NRS)0–10 (no pain to worst pain)During 30 days postoperativeOpioidsMorphin Equivalent Dose (MED)mgDuring 30 days postoperativeCelecoxib, Meloxicam,AcetaminophenDosemgDuring 30 days postoperativeDrainageDo you have wound drainage?Yes/no/bandage still onDuring 30 days postoperativeSwellingDo you have significant swelling?Yes/noDuring 30 days postoperativeForgotten JointHave you forgotten about your joint replacement?0–100%At 1 month postoperativeSastisfactionKnowing what you know now, how likely would you be to have your joint replaced in the future?0–100%At 1 month postoperative Outcomes and their measurement as assessed in the current study. For further information see main text “Methods” Preoperative + 1 month postoperative Celecoxib, Meloxicam, Acetaminophen Preoperative selection of surgical techniques and approaches HR requires excellent bone quality and adequate bone size, usually only met by male patients. HR was indicated if patients met these criteria and additionally were of younger age and engaged in high impact activities, required excessive range of motion or worked in unsafe environments. In patients not meeting these criteria, hip arthroplasty was indicated. The posterior approach was chosen if deformities, morbid obesity, or reduced bone quality required a more extensile approach, longer/straight stems, or modular S-ROM® (DePuy-Synthes, West Chester, PEN, USA) implants. In patients with a pannus or belly overhanging the area of a DAA incision, the PA was preferred as well. In all other patients, a DAA-THA was indicated. Implants A metal on metal Birmingham Hip Resurfacing (Smith and Nephew, London, UK) with an cemented femoral component and an uncemented acetabular component was implanted in all hips undergoing HR. Stems used in THA were: ACTIS (DePuy-Synthes, West Chester, PEN, USA) in 48 DAA-THA, CORAIL (DePuy-Synthes, West Chester, PEN, USA) in 50 DAA-THA, Accolade II (Stryker, Kalamazoo, MI, USA) in 10 hips (9 DAA-THA, 1 PA-THA), Entrada (Ortho Development, Draper, UT, USA) in 12 DAA-THA, Ovation (Ortho Development, Draper, UT, USA) in 2 DAA-THA, Anthology (Smith and Nephew, London, UK) in 2 hips (1 DAA-THA, 1 PA-THA), Summit (DePuy-Synthes, West Chester, PEN, USA) in 2 hips (1 DAA-THA, 1 PA-THA), Synergy (Smith and Nephew, London, UK) in 54 PA-THA, S-ROM (DePuy-Synthes, West Chester, PEN, USA) in 2 PA-THA, Tri-Lock (DePuy-Synthes, West Chester, PEN, USA) in 1 PA-THA. Cups used in THA were: Pinnacle (DePuy-Synthes, West Chester, PEN, USA) in 44 hips (41 DA-THA, 3 PA-THA), Trident II (Stryker, Kalamazoo, MI, USA) in 25 hips (3 DA-THA, 22 PA-THA), Legend (Ortho Development, Draper, UT, USA) in 82 DAA-THA, and R3 (Stryker, Kalamazoo, MI, USA) in 29 PA-THA. In 6 hips, dual mobility implants were used: Polarcup (Smith and Nephew, London, UK) in 3 PA-THA and ADM (Stryker, Kalamazoo, MI, USA) in 3 PA-THA. Stem fixation was cemented in 3 hips (1 DA-THA, 2 PA-THA), all other hips were cementless. Fixation of all cups was cementless. Bearing was metal on polyethylene in 9 DAA-THA and ceramic on polyethylene in all other THA. Postoperative protocol All patients underwent a standardized postoperative protocol including minimal walking within the first week after DAA-THA. Patients followed postoperative hip precautions for 4 weeks after surgery. They were advised to avoid end-range flexion, adduction, and internal rotation (PA, HR) or end-range extension and external rotation (DAA). Beyond that, there were no further restrictions in terms of walking ability and no differences in postsurgical care between DAA-THA, PA-THA, and HR. Data collection As part of the standard care, patients used the SeamlessMD app (Seamless MD, Toronto, Canada) to report postoperative outcomes. The app was used on a smartphone or on a personal computer. Patients reported their pain on a numeric rating scale (NRS), usage of opioids and additional pain medication (name, dosage and number of pills taken), their wound drainage and swelling over a period of 30 days postoperative. Furthermore, the Hip Disability and Osteoarthritis Outcome score – Joint Reconstruction (HOOS-JR) was assessed within two weeks preoperative and at one month postoperative, furthermore patient satisfaction was assessed at one month postoperative. Table 1 depicts the patient related outcome measures (PROM) and medications assessed in the study in detail. To ensure comparability, the opioid intake was transformed into morphine equivalent doses (MED) per day. Additional pain medication used included Acetaminophen, Meloxicam, and Celecoxib, these were transformed into milligram per day for each substance, respectively. For continuous variables, mean values were calculated for 5-day intervals (postoperative day 1–5, 6–10 etc.), to minimize the impact of missing values or one day outliers. Additionally, data on implants, patients’ demographics as well as postoperative complications, readmissions to the hospital, and revision surgeries were assessed by chart review. Statistical analysis Descriptive statistics were performed to describe means range and standard deviation (SD) for all variables. Kolmogorov-Smirnov test (normal distribution) and Levene test (homogeneity) were used as pre-tests. For metric normally distributed demographic values (BMI) univariate ANOVA was performed. For non-parametric independent ordinal/metric demographic variables (age ASA, CCI) Kruskal-Wallis test was performed. Comparisons of metric normally distributed outcome values (medications dosage pain walking distance length of stay forgotten joint [%] satisfaction [%] HOOS) between the surgical groups (DAA-THA PA-THA HR) and correlation of patient satisfaction with pain and HOOS-JR were performed by linear regression with covariate adjustment (age and BMI as potential confounders). Results are displayed as β (Beta coefficient) and p-value. For nominal outcome variables (complications drainage swelling narcotics yes/no) binary logistic regression analysis adjusted for age and BMI was used. Results are displayed as OR (odds ratio) p-value and 95% CI (confidence interval). Bonferroni correction was used for post-hoc-testing. Pearson Correlation was performed to test for correlation between HOOS-JR preoperative and after 1 month. The confidence interval was set at 95%, the significance level was set at α = 0.05. Statistical Analysis was performed with SPSS Statistics 22 (IBM, Armonk, NY, USA). Results Demographics Details on patients’ demographics are provided in Table 2. ASA score was higher in the PA group than the DAA group (p < 0.001) and the HR group (p = 0.002). There were no females in the HR group. This was significantly different from the DAA and PA group (p < 0.001 respectively) and there were less females in the PA group compared to the DAA group (p = 0.028). HR patients were younger than the DAA and PA patients (p < 0.001 respectively). DAA patients had a lower BMI (HR: p < 0.001, PA: p = 0.018). Table 2Patients' demographics and comparison of demographics between HR, DAA-THA, and PA-THA a) Full cohort [mean (range, SD)] DAA [mean (range, SD)] PA [mean (range, SD)] HR [mean (range, SD)] p Age [years]63 (32–90, SD 10)65 (43–90, SD 9)62 (32–82, SD 8)52 (40–69, SD 8)< 0.001*BMI [kg/m²]28.4 (17.5–44.8, SD 5.5)26.0 (17.5–41.2, SD 4.3)33.4 (22.8–44.8, SD 5.0)28.9 (23.3–38.3, SD 3.9)< 0.001**CCI [points]0 (0–7, SD 1)0 (0–7, SD 1)1 (0–6, SD 1)0 (0–2), SD 1)0.842HOOS-JR [%]59 (14–96, SD 14)60 (21–96, SD 14)54 (14–82, SD 15)64 (43–89, SD 12)0.775 b) Full cohort [% (n)] DAA [% (n)] PA [% (n)] HR [% (n)] p Sex (female/male)50/50 (104/103)61/39 (77/49)45/55 (27/33)0/100 (0/21)< 0.001*Laterality (left/right)41/59 (84/123)40/60 (50/76)45/55 (27/33)33/67 (7/14)0.611ASAI• 10 (20)• 12 (15)• 3 (2)• 14 (3)< 0.001**II• 75 (156)• 79 (99)• 65 (39)• 86 (18)III• 15 (31)• 9 (12)• 32 (19)• 0 (0)a) Patients’ demographics (continuous variables). Values are noted as: mean (range, standard deviation)P-values <0.050 were defined as significant* HR patients were significantly younger than DAA patients (p<0.001) or PA patients (p<0.001)** BMI of the DAA-group is significantly lower than for PA (p<0.001) or HR (p =0.018)b) Patients’ demographics (ordinal, binominal variables). Values are noted as percentage (number of cases)P-values <0.050 were defined as significant* There are more males in the HR group than in DAA and PA (p<0.001 respectively) and more females in DAA group compared to PA group (p =0.028)** ASA score is higher in the PA group than in the DAA group (p<0.001) and the HR group (p=0.002)DAA direct anterior approach, PA posterior approach, HR hip resurfacing, BMI body mass index, CCI Charlson Comorbidity Index, HOOS-JR Hip Disability and Osteoarthritis Outcomes Score – Joint Replacement, ASA American Association of Anesthesiologists score Table 2Patients' demographics and comparison of demographics between HR, DAA-THA, and PA-THA a) Full cohort [mean (range, SD)] DAA [mean (range, SD)] PA [mean (range, SD)] HR [mean (range, SD)] p Age [years]63 (32–90, SD 10)65 (43–90, SD 9)62 (32–82, SD 8)52 (40–69, SD 8)< 0.001*BMI [kg/m²]28.4 (17.5–44.8, SD 5.5)26.0 (17.5–41.2, SD 4.3)33.4 (22.8–44.8, SD 5.0)28.9 (23.3–38.3, SD 3.9)< 0.001**CCI [points]0 (0–7, SD 1)0 (0–7, SD 1)1 (0–6, SD 1)0 (0–2), SD 1)0.842HOOS-JR [%]59 (14–96, SD 14)60 (21–96, SD 14)54 (14–82, SD 15)64 (43–89, SD 12)0.775 b) Full cohort [% (n)] DAA [% (n)] PA [% (n)] HR [% (n)] p Sex (female/male)50/50 (104/103)61/39 (77/49)45/55 (27/33)0/100 (0/21)< 0.001*Laterality (left/right)41/59 (84/123)40/60 (50/76)45/55 (27/33)33/67 (7/14)0.611ASAI• 10 (20)• 12 (15)• 3 (2)• 14 (3)< 0.001**II• 75 (156)• 79 (99)• 65 (39)• 86 (18)III• 15 (31)• 9 (12)• 32 (19)• 0 (0)a) Patients’ demographics (continuous variables). Values are noted as: mean (range, standard deviation)P-values <0.050 were defined as significant* HR patients were significantly younger than DAA patients (p<0.001) or PA patients (p<0.001)** BMI of the DAA-group is significantly lower than for PA (p<0.001) or HR (p =0.018)b) Patients’ demographics (ordinal, binominal variables). Values are noted as percentage (number of cases)P-values <0.050 were defined as significant* There are more males in the HR group than in DAA and PA (p<0.001 respectively) and more females in DAA group compared to PA group (p =0.028)** ASA score is higher in the PA group than in the DAA group (p<0.001) and the HR group (p=0.002)DAA direct anterior approach, PA posterior approach, HR hip resurfacing, BMI body mass index, CCI Charlson Comorbidity Index, HOOS-JR Hip Disability and Osteoarthritis Outcomes Score – Joint Replacement, ASA American Association of Anesthesiologists score Patients' demographics and comparison of demographics between HR, DAA-THA, and PA-THA a) Patients’ demographics (continuous variables). Values are noted as: mean (range, standard deviation) P-values <0.050 were defined as significant * HR patients were significantly younger than DAA patients (p<0.001) or PA patients (p<0.001) ** BMI of the DAA-group is significantly lower than for PA (p<0.001) or HR (p =0.018) b) Patients’ demographics (ordinal, binominal variables). Values are noted as percentage (number of cases) P-values <0.050 were defined as significant * There are more males in the HR group than in DAA and PA (p<0.001 respectively) and more females in DAA group compared to PA group (p =0.028) ** ASA score is higher in the PA group than in the DAA group (p<0.001) and the HR group (p=0.002) DAA direct anterior approach, PA posterior approach, HR hip resurfacing, BMI body mass index, CCI Charlson Comorbidity Index, HOOS-JR Hip Disability and Osteoarthritis Outcomes Score – Joint Replacement, ASA American Association of Anesthesiologists score Postoperative pain and pain management Pain reduced from 4.8 NRS (0.0–8.3.0.3, SD 1.8) within the first 5 postoperative days to 1.8 (0.0–6.0, SD 1.6) after 25 days. 70.5% of cases (n = 146) had a maximum pain of 2.0 at 30 days. There were no significant differences during the first 30 days following surgery between the groups. The postoperative pain levels are displayed in Fig. 1. Further detailed results of the statistical analysis can be found in the appendix to this manuscript. Fig. 1Postoperative pain levels following DAA-THA, PA-THA, and HR. Mean pain on a numeric rating scale from 0–10 (0 = no pain and 10 = worst pain) during the first 30 days postoperative. There were no significant differences between the groups. See main text “Results” for further details Postoperative pain levels following DAA-THA, PA-THA, and HR. Mean pain on a numeric rating scale from 0–10 (0 = no pain and 10 = worst pain) during the first 30 days postoperative. There were no significant differences between the groups. See main text “Results” for further details Figure 2 and Table 3 report details on the usage of opioids following surgery. Over the whole course, there were no differences in the mean dosage between the DAA-THA, PA-THA and HR. Between postoperative day 6 and 15 DAA patients took more Acetaminophen compared to PA patients (β −428.198, p = 0.022/β −333.302, p = 0.070) and HR patients (β−520.437, p = 0.035/β −648.413, p = 0.008). Between day 11–15, DAA patients took more Celecoxib compared to HR patients (β−648.413, p = 0.008). There were no other differences between the groups. Further detailed results of the statistical analysis can be found in the appendix to this manuscript.Table 3Usage of opioids in the full cohort and subgroups. Dosage is reported in milligram morphine equivalent doses (MED). Values are presented as mean dose (standard deviation SD). Differences between direct anterior approach total hip arthroplasty (DAA), posterior approach total hip arthroplasty (PA) and hip resurfacing (HR) were not significant in all intervals (p>0.050)PostoperativeDaysFull cohohrtDAAPAHRSignificanceMean daily usage of narcotics in morphine equivalent doses [mg] (SD)p1–58.9 (9.3)8.0 (8.9)10.3 (11.3)8.9 (6.4)0.0566–102.3 (5.5)2.3 (5.7)2.8 (5.7)0.9 (3.3)0.44311–150.5 (2.9)0.5 (3.2)0.7(2.6)0.9 (0.4)0.94016–200.4 (2.0)0.2 (1.7)0.8 (2.7)0.2 (0.8)0.31721–250.1 (0.6)0.1 (0.7)0.0 (0.0)0.0 (0.0)0.86926–300.0 (0.4)0.1 (0.5)0.0 (0.0)0.0 (0.0)0.697 Table 3Usage of opioids in the full cohort and subgroups. Dosage is reported in milligram morphine equivalent doses (MED). Values are presented as mean dose (standard deviation SD). Differences between direct anterior approach total hip arthroplasty (DAA), posterior approach total hip arthroplasty (PA) and hip resurfacing (HR) were not significant in all intervals (p>0.050)PostoperativeDaysFull cohohrtDAAPAHRSignificanceMean daily usage of narcotics in morphine equivalent doses [mg] (SD)p1–58.9 (9.3)8.0 (8.9)10.3 (11.3)8.9 (6.4)0.0566–102.3 (5.5)2.3 (5.7)2.8 (5.7)0.9 (3.3)0.44311–150.5 (2.9)0.5 (3.2)0.7(2.6)0.9 (0.4)0.94016–200.4 (2.0)0.2 (1.7)0.8 (2.7)0.2 (0.8)0.31721–250.1 (0.6)0.1 (0.7)0.0 (0.0)0.0 (0.0)0.86926–300.0 (0.4)0.1 (0.5)0.0 (0.0)0.0 (0.0)0.697 Usage of opioids in the full cohort and subgroups. Dosage is reported in milligram morphine equivalent doses (MED). Values are presented as mean dose (standard deviation SD). Differences between direct anterior approach total hip arthroplasty (DAA), posterior approach total hip arthroplasty (PA) and hip resurfacing (HR) were not significant in all intervals (p>0.050) Fig. 2Usage of opioids. (a) Daily usage of opioids in morphine equivalent doses (MED, [mg]) in each patient. (b) Mean daily usage of opioids in patients with direct anterior approach total hip arthroplasty, posterior approach total hip arthroplasty, and hip resurfacing. There were no significant differences between the groups. See main text “Results” for further details Usage of opioids. (a) Daily usage of opioids in morphine equivalent doses (MED, [mg]) in each patient. (b) Mean daily usage of opioids in patients with direct anterior approach total hip arthroplasty, posterior approach total hip arthroplasty, and hip resurfacing. There were no significant differences between the groups. See main text “Results” for further details Although the overall statistical model showed differences in the percentage of patients using narcotics within the first 5 days following surgery (p = 0.020), the type of surgery was not a predictor of opioid usage after adjusting for age and BMI (DAA/PA: OR 0.692, p = 0.489, 95% CI 0.244–1.963; DAA/HR: OR 1.388, p = 0.698, 95% CI 0.272–7.070; PA/HR: OR 2.005, p = 0.431, 95% CI 0.355–11.307; BMI: OR 1.115, p = 0.020, 95% CI 1.017–1.222; age: OR 0.972, p = 0.168, 95% CI 0.933–1.012). Afterwards, no significant differences were found. 70.5% of cases (n = 146) were off opioids after 10 days, 92.3% (n = 191) after 15 days and 99.0% (n = 205) from day 20 on, respectively. Functional outcome and patient satisfaction Within the first 5 days, the DAA group had a shorter walking distance than the HR group and the PA group (β HR 318.238, p = 0.007; β PA 342.900, p < 0.001). Between day 6–25 following surgery, the DAA group had a shorter walking distance than the PA group (β PA 831.798/1065.837/1553.33/1165.32, p < 0.001/p = 0.003/p = 0.001/p = 0.016). Thereafter, the walking ability did not differ. Further detailed results of the statistical analysis can be found in the appendix to this manuscript. The mean walking distance after 25 days was 2.2 km (0.0–10.6 km, SD 1.9). The walking distance increased most rapidly in the beginning with 220% between the first two intervals, slowing down to 130% increase between intervals 5 and 6. The average changes from pre- to postoperative HOOS-JR was 23 points (−29−82, SD 15), improvement was significant in all groups (p < 0.001, respectively). There were no differences in HOOS-JR between the groups at the 1 month follow-up (p = 0.588, β HR 0.106, p = 0.968; β PA 2.318, p = 0.245). Results are presented in Fig. 3. Pre- and postoperative scores correlated for DAA (p = 0.004) and HR (p = 0.046). Fig. 3Hip disability and Osteoarthritis Outcome Score – Joint Replacement (HOOS-JR). Scale from 0–100 with 0 = worst function to 100 = best function. HOOS-JR improved significantly from 59 points (14–96 points, SD 14) preoperative to 82 points (53–100, SD 10) postoperative (p < 0.001) Hip disability and Osteoarthritis Outcome Score – Joint Replacement (HOOS-JR). Scale from 0–100 with 0 = worst function to 100 = best function. HOOS-JR improved significantly from 59 points (14–96 points, SD 14) preoperative to 82 points (53–100, SD 10) postoperative (p < 0.001) One month postoperative, patients had forgotten about their joint replacement in 52% of the cases (HR 47% < DAA 51% < PA 55%), differences between the groups were not significant (p = 0.732, β PA 0.021, p = 0.700, 95% CI −0.087−0.129; β HR −0.055, p = 0.794, 95% CI −0.005−0.004). When asked knowing what they know now, how likely they would have their joint replaced again, 88% of the patients showed a high satisfaction (> 80% agreement). In average, the agreement was 91% (DAA 89%, SD 23/HR 90%, SD 20/PA 95%, SD12). There were no significant differences between the groups (p = 0.209, β PA 0.032, p = 0.402, 95% CI −0.043−0.107; β HR −0.003, p = 0.954, 95% CI −0.102−0.096). Satisfaction showed correlation with pain (p = 0.002) and HOOS-JR (p < 0.001). Hospital stay, drainage, swelling, and complications The mean duration of the hospital stay was < 1 day for all groups. Statistically, the type of surgery did affect the length of stay with shorter stays in the HR group compared to the DAA group (β HR: −0.31, p=−0.036, 95% CI −0.599−0.020; β PA: −0.166, p = 0.167, 95% CI −0.385−0.053). However, with differences < 1 day between the groups, the effect did not reach clinical relevance. The maximum length of stay was 3 days for DAA-THA and 1 day for PA-THA and HR (SD in all groups < 1). Details on wound drainage and swelling are presented in Fig. 4. After 10 days postoperative, there was no wound drainage in 99% of the cases. No differences were found for wound drainage and swelling between the groups. Further detailed results of the statistical analysis can be found in the appendix to this manuscript. No delayed wound healing (DWH), surgical site infections (SSI), periprosthetic joint infections (PJI), deep vein thromboses, fractures or dislocations were reported within the first 30 days following surgery. Thereafter there were complications in 2.9% of the cases, including 6 DWH (4 DAA, 2 PA). Four cases required revision surgery with wound incision and drainage, one with deep irrigation and debridement after an average of 39 days postoperative (range 31–54). Complication rates did not differ between the groups (p = 0.437; OR PA 0.519, p = 0.565, 95% CI 0.565 − 0.056; OR HR 3.92*10− 8, p = 0.994, 95% CI 0.00-∞). Fig. 4(a) Wound drainage. Wound situation in % of cases at each time interval. From postoperative day 16 on, all patients had removed the bandages and 99% of the wounds were dry. (b) Swelling. Local swelling over time as reported by the patients (in % of cases). The rate decreased from 62% between day 1–5 to 14% between day 26–30 (a) Wound drainage. Wound situation in % of cases at each time interval. From postoperative day 16 on, all patients had removed the bandages and 99% of the wounds were dry. (b) Swelling. Local swelling over time as reported by the patients (in % of cases). The rate decreased from 62% between day 1–5 to 14% between day 26–30 Discussion Pain and opioids The study’s main aim was to examine pain and the usage of narcotics in the early period following hip reconstructive surgery and to compare outcomes between the most common performed reconstructive surgeries at the authors’ institution (DAA-THA, PA-THA, and HR). Neither pain nor the postoperative utilization of opioids did differ between the three groups and 99% of the patients had stopped opioids as of postoperative day 20. In the wake of the opiate crisis in the U.S., attention has been drawn regarding prescriptions following orthopedic surgery. Shah et al. had suggested that more opioids may be prescribed than necessary after arthroplasty surgery [18]. The patients’ opiate requirement depends on their pain, however, the interaction between pain, demand of narcotics and multiple psycho-emotional factors is complex and not fully understood. Such as pain catastrophizing that has been found to correlate with experienced pain, however, not with opioid use [19, 20]. While surgeons claim benefits in early pain control for different approaches, the current study did not confirm this. Lower pain on postoperative day 1 and a better pain reduction after 6 weeks has been reported for patients with DAA-THA compared to PA-THA [7, 21–24]. Contradictory results were published in a randomized controlled trial by Moerenhout et al. who found no difference between DAA and PA regarding pain [25]. Furthermore, HR was reported to be associated with higher pain levels than THA [26]. The current results did not support the assumption that any of the procedures were superior regarding early postoperative pain. Furthermore, contradictory to a meta-analysis by Miller et al., the current study showed no differences in the postoperative utilization of narcotics between HR, DAA-THA and PA-THA [22]. The initial hypothesis that >95% of the patients would have stopped taking narcotics within a week postoperative has not been fully supported by the current data. However, opioid cessation was 99% within less than three weeks after surgery. Patient satisfaction The average reported satisfaction, measured as “Knowing what you know now, how likely would you have your joint replaced in the future?” in the current study was high with >89% agreement in each group. Yet, there were negative outliers and the rate of patients with high satisfaction after one month (88%) was below the hypothesized rate. Previous studies showed that pain may influence patient satisfaction and can be linked to worse functional results following arthroplasty surgery [27, 28]. Furthermore, Fujita et al., found patient satisfaction to be correlated with activity levels [29]. This is supported by the current results as lower satisfaction correlated with higher pain (p = 0.002) and lower HOOS-JR (p < 0.001). It may hereby be suggested that subjective factors or patient expectations impact satisfaction within the early postoperative period. Function and complications In this study, the function showed significant improvement following surgery without differences between the groups. From preoperative to one month postoperative, the HOOS-JR increased 23 points on average, which is above the reported minimal clinical important difference of 18 points improvement within one year [30]. The DAA surgical site may be more likely to develop DWH due to increased friction and changes in skin tension while walking and raising/sitting. To prevent this, the postoperative protocol in the current study advised DAA patients to keep physical activity low for the first postoperative week. Walking distances in the DAA group remained shorter for the first 25 days, however aligned afterwards, suggesting that the described postoperative protocol does not impair rehabilitation in the long run. Whether certain approaches are more likely to develop complications is under discussion. A meta-analysis by Miller et al., comparing DAA-THA with PA-THA and found no differences for DWH but fewer infection with DAA, while Bendich et al. reported no differences in infection rates between the approaches [31, 32]. Further studies also reported similar complication rates for the different procedures and approaches [9, 25, 33, 34]. This is in line with the current study where no differences in complication rates were found. The overall complication rate of 2.9% DWH 31–54 days after surgery is within the range reported in literature [35, 36]. Furthermore, there were no major complications such as dislocations, fractures or PJI in the current cohort. Thus, suggesting that none of the procedures is superior regarding the risk for early complications and complication rates are generally low. Demographics Numerous reconstructive surgical techniques exist and have proven successful, nevertheless there is an ongoing discussion about benefits and disadvantages of each procedure. The most common performed surgeries at the authors` institution are DAA-THA, PA-THA and HR. Due to the narrow indication criteria for HR, this procedure is overall performed less frequently than THA and there are demographic particularities. Due to the necessity of good bone quality and renal function as well as the contraindication for women in childbearing age, HR is more frequently performed in men and younger patients [37]. The aim to prevent DWH due to overhanging abdominal pannus caused that DAA patients had a lower average BMI [38]. However, it was a crucial part of the current study to reflect the clinical setting. We hypothesized that after applying the narrow indication criteria as stated in the methods section and choosing the surgical technique for patients with arthritis or aseptic osteonecrosis with respect to their individual features, patients will show similar outcomes within the early postoperative period. There is a risk that variances in demographics may function as confounders and that differences in case numbers reduce statistical robustness. However, after adjusting for age and BMI the groups did show similar outcomes. This underlines the importance of choosing the procedure and approach with respect to the patients’ individual particularities to obtain adequate results. Limitations There are limitations to this study: (1) due to the retrospective study design, only patients who reported PROMs using the SeamlessMD app could be included in the study, (2) the groups sizes were unequal with smaller case numbers for HR. This might negatively impact the statistical analysis comparing the HR group to others and increases the risk of a type 2 statistical error, (3) due to procedure specific requirements, there are demographic differences between DAA-THA, PA-THA and HR groups, (4) no matching has been performed due to limited case numbers and the procedure-specific requirements to the patient’s demographics which would cause a relevant loss of cases if matched and exclusion of relevant patient groups such as females. Potential confounders have therefore been addressed by linear regression with covariate adjustment instead of matching. Nevertheless, further studies on larger cohorts should be conducted to address potential confounders in more detail, (5) the study is based on information provided by the patients themselves and therefore depends on the patients’ reliability, (6) there is variability in the used implants, however this impact may be limited due to the single-surgeon design and short-term follow-up. Conclusion The study showed that 99% of the patients stopped using narcotics within less than three weeks following hip reconstructive surgery. The early postoperative outcome including pain, opioid usage, function, and complications showed similar results for patients with HR, DAA-THA, and PA-THA. This may suggest that if fixed indication criteria for each procedure are set and hereby the procedure is chosen according to patient characteristics, none of the surgeries seems to be superior itself. Supplementary Information Supplementary Material 1. Supplementary Material 1. Supplementary Material 2. Supplementary Material 2. Supplementary Material 3. Supplementary Material 3. Supplementary Material 4. Supplementary Material 4. Supplementary Material 5. Supplementary Material 5. Supplementary Material 6. Supplementary Material 6. Supplementary Material 7. Supplementary Material 7.